Skin Diseases Completed Phase 2 Trials for Abrocitinib (DB14973)

Also known as: Skin Disease / Iatrogenic dermatosis / Disease of skin (disorder) / Skin disorder / Dermatosis / Skin disorder NOS

IndicationStatusPhase
DBCOND0028161 (Skin Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05038982Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown OriginTreatment